Scopoletin Augments DJ1/Nrf2 Signalling and Prevents Protein Aggregation in Parkinson’s disease
S Narasimhan Kishore Kumar, Jayakumar Deepthy, Velusamy Prema, Srinivasan Ashokkumar, Mohan Thangarajeswari, Ravi Divya Bhavani, Uthamaraman Saraswathi, Sathyamoorthy Yogesh Kanna, Namakal S. Rajasekaran, Periandavan Kalaiselvi
This study shows scopoletin reduces oxidative stress and protein aggregation in Parkinson’s disease by enhancing DJ-1/Nrf2 signaling and preventing neuronal damage.
bioRxiv · Feb 5, 2018 · PreprintBiochemistry